Peroxiredoxin I is a negative regulator of Th2-dominant allergic asthma |
| |
Institution: | 1. Department of Human Sciences, The Ohio State University, Columbus, OH 43210, USA;2. Center for Molecular and Human Genetics, The Research Institute at Nationwide Children''s Hospital, Columbus, OH 43205, USA;3. Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH 43210, USA;4. Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA;5. Nucleic Acid Shared Resource, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA;6. Division of Hematology, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA |
| |
Abstract: | Peroxiredoxin (Prx) I, a ubiquitous antioxidant enzyme, is known to protect against inflammation; however, its role in the allergic inflammation remains unidentified. We determined whether intristic Prx I protects against allergic asthma traits using Prx-I knockout (?/?) mice. Prx I (?/?) and wild-type (WT) mice were immunized with ovalbumin (OVA) plus aluminum potassium sulfate (Alum: Th2 adjuvant) and subsequently challenged with OVA. Twenty-four hours after the last OVA challenge, leukocyte influx including eosinophils into bronchoalveolar lavage fluid was significantly greater in Prx I (?/?) mice compared to that in WT mice. On the other hand, when these mice were immunized with OVA + complete Freund's adjuvant (Th1 adjuvant), opposite phenomenon was observed. In the presence of OVA/Alum, peribronchial inflammatory leukocyte infiltration, cholinergic airway resistance, and the lung expression of interleukin (IL)-2 were significantly greater and that of interferon-γ was significantly lesser in Prx I (?/?) than in WT mice. In vitro, OVA/Alum-sensitized Prx I (?/?) T cells proliferated more profoundly than WT T cells when they were cocultured with syngeneic bone marrow-generated dendritic cells. These results indicate that endogenous Prx I protects against allergen-related Th2-type airway inflammation and hyperresponsiveness, at least partly, via the suppression of the lung expression of IL-2 and regulation of the Th1/Th2 balance in addition to its antioxidative properties. Furthermore, Prx I can inhibit allergen-specific T-cell proliferation through immunological synapse. Our findings implicate an alternative therapeutic value of Prx I in the treatment of Th2-skewed allergic airway inflammatory diseases such as atopic asthma. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|